Efficacy and safety of Aviron Rapid® in adolescents and children with viral acute upper respiratory tract infection: a multi-center, randomized, double blind, placebo-controlled clinical trial


	Patient disposition (Safety Analysis). Safety analysis included all patients who received at least one dose of Aviron Rapid or placebo. Efficacy analysis included all patients who completed treatment and all planned trial visits per protocol, and did not have protocol deviations.

Part of: Markova RM, Tzotcheva IS, Perenovska P, Mangarov A, Nikolaeva-Glomb L, Hadjiev V (2023) Efficacy and safety of Aviron Rapid® in adolescents and children with viral acute upper respiratory tract infection: a multi-center, randomized, double blind, placebo-controlled clinical trial. Folia Medica 65(4): 546-568. https://doi.org/10.3897/folmed.65.e108153